Union européenne - tchèque - EMA (European Medicines Agency)

amgen europe bv - sotorasib - karcinom, plicní jiná než malobuněčná - antineoplastická činidla - lumykras as monotherapy is indicated for the treatment of adults with advanced non-small cell lung cancer (nsclc) with kras g12c mutation and who have progressed after at least one prior line of systemic therapy.

Union européenne - tchèque - EMA (European Medicines Agency)

laboratorios lesvi s.l. - dimethyl fumarát - roztroušená skleróza, relaps-remitentní - imunosupresiva - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Union européenne - tchèque - EMA (European Medicines Agency)

accord healthcare s.l.u. - teriparatid - osteoporóza - vápníková homeostáza - sondelbay is indicated in adults. léčba osteoporózy u postmenopauzálních žen a u mužů se zvýšeným rizikem zlomenin. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures have been demonstrated. léčba osteoporózy spojené s trvalou terapií systémovými glukokortikoidy u žen a mužů se zvýšeným rizikem zlomenin.

Union européenne - tchèque - EMA (European Medicines Agency)

merck europe b.v. - tepotinib hydrochloride monohydrate - karcinom, plicní jiná než malobuněčná - antineoplastická činidla - tepmetko as monotherapy is indicated for the treatment of adult patients with advanced non-small cell lung cancer (nsclc) harbouring alterations leading to mesenchymal-epithelial transition factor gene exon 14 (metex14) skipping, who require systemic therapy following prior treatment with immunotherapy and/or platinum-based chemotherapy.

Union européenne - tchèque - EMA (European Medicines Agency)

pierre fabre medicament - tabelecleucel - lymphoproliferative disorders - ebvallo is indicated as monotherapy for treatment of adult and paediatric patients 2 years of age and older with relapsed or refractory epstein-barr virus positive post-transplant lymphoproliferative disease (ebv+ ptld) who have received at least one prior therapy. for solid organ transplant patients, prior therapy includes chemotherapy unless chemotherapy is inappropriate.

Union européenne - tchèque - EMA (European Medicines Agency)

theramex ireland limited - abaloparatide - osteoporosis, postmenopausal; osteoporosis - vápníková homeostáza - léčba osteoporózy u postmenopauzálních žen se zvýšeným rizikem zlomenin.

Union européenne - tchèque - EMA (European Medicines Agency)

sun pharmaceutical industries europe b.v. - teriparatid - osteoporosis; osteoporosis, postmenopausal - vápníková homeostáza - teriparatide sun is indicated in adults. treatment of osteoporosis in postmenopausal women and in men at increased risk of fracture (see section 5. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures has been demonstrated. treatment of osteoporosis associated with sustained systemic glucocorticoid therapy in women and men at increased risk for fracture (see section 5.

Union européenne - tchèque - EMA (European Medicines Agency)

strides pharma (cyprus) limited - teriparatid - osteoporosis; osteoporosis, postmenopausal - vápníková homeostáza - kauliv is indicated in adults. treatment of osteoporosis in postmenopausal women and in men at increased risk of fracture (see section 5. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures has been demonstrated. treatment of osteoporosis associated with sustained systemic glucocorticoid therapy in women and men at increased risk for fracture (see section 5.

République tchèque - tchèque - SUKL (Státní ústav pro kontrolu léčiv)

teva pharmaceuticals cr, s.r.o., praha array - 76 amfotericin b - koncentrát pro infuzní disperzi - 5mg/ml - amfotericin b

République tchèque - tchèque - SUKL (Státní ústav pro kontrolu léčiv)

medochemie bohemia, spol. s r.o., praha array - 11409 sodnÁ sŮl cefoperazonu pro injekci - prášek pro injekční/infuzní roztok - 1g - cefoperazon